• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A-to-I 编辑在非霍奇金淋巴瘤中具有亚型特异性。

A-to-I Editing Is Subtype-Specific in Non-Hodgkin Lymphomas.

机构信息

Biophysics Graduate Program, The Ohio State University, Columbus, OH 43210, USA.

Center for RNA Biology, The Ohio State University, Columbus, OH 43210, USA.

出版信息

Genes (Basel). 2024 Jul 1;15(7):864. doi: 10.3390/genes15070864.

DOI:10.3390/genes15070864
PMID:39062643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11276283/
Abstract

Cancer is a complex and heterogeneous disease, in which a number of genetic and epigenetic changes occur in tumor onset and progression. Recent studies indicate that changes at the RNA level are also involved in tumorigenesis, such as adenosine-to-inosine (A-to-I) RNA editing. Here, we systematically investigate transcriptome-wide A-to-I editing events in a large number of samples from Non-Hodgkin lymphomas (NHLs). Using a computational pipeline that determines significant differences in editing level between NHL and normal samples at known A-to-I editing sites, we identify a number of differentially edited editing sites between NHL subtypes and normal samples. Most of the differentially edited sites are located in non-coding regions, and many such sites show a strong correlation between gene expression level and editing efficiency, indicating that RNA editing might have direct consequences for the cancer cell's aberrant gene regulation status in these cases. Moreover, we establish a strong link between RNA editing and NHL by demonstrating that NHL and normal samples and even NHL subtypes can be distinguished based on genome-wide RNA editing profiles alone. Our study establishes a strong link between RNA editing, cancer and aberrant gene regulation in NHL.

摘要

癌症是一种复杂且异质性的疾病,其中许多遗传和表观遗传变化发生在肿瘤的发生和进展过程中。最近的研究表明,RNA 水平的变化也参与了肿瘤发生,如腺苷到肌苷(A-to-I)RNA 编辑。在这里,我们系统地研究了大量非霍奇金淋巴瘤(NHL)样本中的全转录组 A-to-I 编辑事件。使用一种计算管道,该管道确定了在已知 A-to-I 编辑位点处 NHL 和正常样本之间编辑水平的显著差异,我们鉴定出 NHL 亚型和正常样本之间存在许多差异编辑的编辑位点。大多数差异编辑的位点位于非编码区域,许多这样的位点显示基因表达水平和编辑效率之间存在很强的相关性,表明在这些情况下,RNA 编辑可能对癌细胞的异常基因调控状态有直接影响。此外,我们通过证明 NHL 和正常样本甚至 NHL 亚型可以仅基于全基因组 RNA 编辑谱来区分,建立了 RNA 编辑与 NHL 之间的强联系。我们的研究在 NHL 中建立了 RNA 编辑、癌症和异常基因调控之间的强联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d4/11276283/ee1e037afa00/genes-15-00864-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d4/11276283/ec6123d4ce6c/genes-15-00864-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d4/11276283/18f5fd540c7b/genes-15-00864-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d4/11276283/ef9e604abb11/genes-15-00864-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d4/11276283/ee1e037afa00/genes-15-00864-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d4/11276283/ec6123d4ce6c/genes-15-00864-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d4/11276283/18f5fd540c7b/genes-15-00864-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d4/11276283/ef9e604abb11/genes-15-00864-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d4/11276283/ee1e037afa00/genes-15-00864-g004.jpg

相似文献

1
A-to-I Editing Is Subtype-Specific in Non-Hodgkin Lymphomas.A-to-I 编辑在非霍奇金淋巴瘤中具有亚型特异性。
Genes (Basel). 2024 Jul 1;15(7):864. doi: 10.3390/genes15070864.
2
Biochemical and Transcriptome-Wide Identification of A-to-I RNA Editing Sites by ICE-Seq.通过ICE-Seq对A到I RNA编辑位点进行生化和全转录组鉴定
Methods Enzymol. 2015;560:331-53. doi: 10.1016/bs.mie.2015.03.014. Epub 2015 Jul 9.
3
A computational screen for site selective A-to-I editing detects novel sites in neuron specific Hu proteins.一种用于位点选择性 A 到 I 编辑的计算筛选方法检测到神经元特异性 Hu 蛋白中的新位点。
BMC Bioinformatics. 2010 Jan 4;11:6. doi: 10.1186/1471-2105-11-6.
4
A-to-I RNA editing - thinking beyond the single nucleotide.A-to-I RNA 编辑——超越单核苷酸的思考。
RNA Biol. 2017 Dec 2;14(12):1690-1694. doi: 10.1080/15476286.2017.1364830. Epub 2017 Oct 11.
5
Transcriptome-wide identification of A > I RNA editing sites by inosine specific cleavage.通过次黄嘌呤特异性切割在转录组范围内鉴定 A > I RNA 编辑位点。
RNA. 2013 Feb;19(2):257-70. doi: 10.1261/rna.036202.112. Epub 2012 Dec 21.
6
Clinical Relevance of Noncoding Adenosine-to-Inosine RNA Editing in Multiple Human Cancers.非编码腺嘌呤到肌苷RNA编辑在多种人类癌症中的临床相关性
JCO Clin Cancer Inform. 2019 Jun;3:1-8. doi: 10.1200/CCI.18.00151.
7
Identification of Diverse Adenosine-to-Inosine RNA Editing Subtypes in Colorectal Cancer.鉴定结直肠癌中多样化的腺苷到肌苷 RNA 编辑亚型。
Cancer Res Treat. 2017 Oct;49(4):1077-1087. doi: 10.4143/crt.2016.301. Epub 2017 Jan 25.
8
One hundred million adenosine-to-inosine RNA editing sites: hearing through the noise.一亿个腺苷到肌苷的RNA编辑位点:从噪音中聆听
Bioessays. 2014 Aug;36(8):730-5. doi: 10.1002/bies.201400055. Epub 2014 May 30.
9
Large-scale detection and analysis of adenosine-to-inosine RNA editing during development in Plutella xylostella.小菜蛾发育过程中腺苷到肌苷RNA编辑的大规模检测与分析
Mol Genet Genomics. 2015 Jun;290(3):929-37. doi: 10.1007/s00438-014-0968-4. Epub 2014 Dec 10.
10
A survey on cellular RNA editing activity in response to Candida albicans infections.关于细胞 RNA 编辑活性对白色念珠菌感染反应的调查。
BMC Genomics. 2018 Jan 19;19(Suppl 1):43. doi: 10.1186/s12864-017-4374-2.

本文引用的文献

1
PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer.PRKCSH 可作为泛癌的潜在免疫和预后生物标志物。
Sci Rep. 2024 Jan 20;14(1):1778. doi: 10.1038/s41598-024-52153-w.
2
RNA Editing in Cancer Progression.癌症进展中的RNA编辑
Cancers (Basel). 2023 Nov 3;15(21):5277. doi: 10.3390/cancers15215277.
3
FLARE: a fast and flexible workflow for identifying RNA editing foci.FLARE:一种快速灵活的 RNA 编辑焦点识别工作流程。
BMC Bioinformatics. 2023 Oct 2;24(1):370. doi: 10.1186/s12859-023-05452-4.
4
ADAR1-mediated RNA editing promotes B cell lymphomagenesis.ADAR1介导的RNA编辑促进B细胞淋巴瘤的发生。
iScience. 2023 May 12;26(6):106864. doi: 10.1016/j.isci.2023.106864. eCollection 2023 Jun 16.
5
RNA modification mapping with JACUSA2.使用 JACUSA2 进行 RNA 修饰图谱绘制。
Genome Biol. 2022 May 16;23(1):115. doi: 10.1186/s13059-022-02676-0.
6
A novel mechanism for A-to-I RNA-edited AZIN1 in promoting tumor angiogenesis in colorectal cancer.一种由A到I RNA编辑的AZIN1促进结直肠癌肿瘤血管生成的新机制。
Cell Death Dis. 2022 Apr 2;13(4):294. doi: 10.1038/s41419-022-04734-8.
7
A-to-I RNA Editing in Cancer: From Evaluating the Editing Level to Exploring the Editing Effects.癌症中的A到I RNA编辑:从评估编辑水平到探索编辑效应
Front Oncol. 2021 Feb 11;10:632187. doi: 10.3389/fonc.2020.632187. eCollection 2020.
8
Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma.组织蛋白酶 S 的改变诱导滤泡性淋巴瘤中促进肿瘤的免疫微环境。
Cell Rep. 2020 May 5;31(5):107522. doi: 10.1016/j.celrep.2020.107522. Epub 2020 Apr 23.
9
Statistical inference of differential RNA-editing sites from RNA-sequencing data by hierarchical modeling.基于层次模型的 RNA 测序数据分析差异 RNA 编辑位点的统计推断。
Bioinformatics. 2020 May 1;36(9):2796-2804. doi: 10.1093/bioinformatics/btaa066.
10
Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer.AZIN1 RNA 编辑的激活是促进结直肠癌中癌相关成纤维细胞侵袭潜能的一种新机制。
Cancer Lett. 2019 Mar 1;444:127-135. doi: 10.1016/j.canlet.2018.12.009. Epub 2018 Dec 21.